190 related articles for article (PubMed ID: 25715169)
21. Pyropheophorbide A and c(RGDyK) comodified chitosan-wrapped upconversion nanoparticle for targeted near-infrared photodynamic therapy.
Zhou A; Wei Y; Wu B; Chen Q; Xing D
Mol Pharm; 2012 Jun; 9(6):1580-9. PubMed ID: 22533630
[TBL] [Abstract][Full Text] [Related]
22. PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy.
Li Z; Wang C; Cheng L; Gong H; Yin S; Gong Q; Li Y; Liu Z
Biomaterials; 2013 Dec; 34(36):9160-70. PubMed ID: 24008045
[TBL] [Abstract][Full Text] [Related]
23. Folic Acid Functionalized Chlorin e6-Superparamagnetic Iron Oxide Nanocarriers as a Theranostic Agent for MRI-Guided Photodynamic Therapy.
Sun Z; Luo M; Li J; Wang A; Sun X; Wu Q; Li K; Ma Y; Yang C; Li X
J Biomed Nanotechnol; 2021 Feb; 17(2):205-215. PubMed ID: 33785092
[TBL] [Abstract][Full Text] [Related]
24. Monomeric pheophorbide(a)-containing poly(ethyleneglycol-b-epsilon-caprolactone) micelles for photodynamic therapy.
Knop K; Mingotaud AF; El-Akra N; Violleau F; Souchard JP
Photochem Photobiol Sci; 2009 Mar; 8(3):396-404. PubMed ID: 19255682
[TBL] [Abstract][Full Text] [Related]
25. Iron oxide nanoparticles functionalized with novel hydrophobic and hydrophilic porphyrins as potential agents for photodynamic therapy.
Penon O; Marín MJ; Amabilino DB; Russell DA; Pérez-García L
J Colloid Interface Sci; 2016 Jan; 462():154-65. PubMed ID: 26454374
[TBL] [Abstract][Full Text] [Related]
26. Red emitting conjugated polymer based nanophotosensitizers for selectively targeted two-photon excitation imaging guided photodynamic therapy.
Duan X; Jiang XF; Hu D; Liu P; Li S; Huang F; Ma Y; Xu QH; Cao Y
Nanoscale; 2018 Dec; 11(1):185-192. PubMed ID: 30525149
[TBL] [Abstract][Full Text] [Related]
27. Coumarin-poly(2-oxazoline)s as synergetic and protein-undetected nanovectors for photodynamic therapy.
Heaugwane D; Cerlati O; Belkhir K; Tarek Benkhaled B; Catrouillet S; Fabing I; Claparols C; Vedrenne M; Goudounèche D; Payré B; Lucia Bona B; Tosi A; Baldelli Bombelli F; Vicendo P; Lapinte V; Lonetti B; Mingotaud AF; Gibot L
Int J Pharm; 2024 Jun; 658():124186. PubMed ID: 38701908
[TBL] [Abstract][Full Text] [Related]
28. Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity.
Hwang JW; Jung SJ; Cheong TC; Kim Y; Shin EP; Heo I; Kim G; Cho NH; Wang KK; Kim YR
J Phys Chem B; 2019 Aug; 123(31):6776-6783. PubMed ID: 31310131
[TBL] [Abstract][Full Text] [Related]
29. 131I-Zn-Chlorophyll derivative photosensitizer for tumor imaging and photodynamic therapy.
Ocakoglu K; Er O; Kiyak G; Lambrecht FY; Gunduz C; Kayabasi C
Int J Pharm; 2015 Sep; 493(1-2):96-101. PubMed ID: 26226337
[TBL] [Abstract][Full Text] [Related]
30. Dual-modal imaging and photodynamic therapy using upconversion nanoparticles for tumor cells.
Yang C; Liu Q; He D; Na N; Zhao Y; Ouyang J
Analyst; 2014 Dec; 139(24):6414-20. PubMed ID: 25327945
[TBL] [Abstract][Full Text] [Related]
31. Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for in vivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers.
Zhang L; Zeng L; Pan Y; Luo S; Ren W; Gong A; Ma X; Liang H; Lu G; Wu A
Biomaterials; 2015 Mar; 44():82-90. PubMed ID: 25617128
[TBL] [Abstract][Full Text] [Related]
32. A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study.
Rapozzi V; Varchi G; Della Pietra E; Ferroni C; Xodo LE
Invest New Drugs; 2017 Feb; 35(1):115-123. PubMed ID: 27726093
[TBL] [Abstract][Full Text] [Related]
33. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach.
Pandey SK; Gryshuk AL; Sajjad M; Zheng X; Chen Y; Abouzeid MM; Morgan J; Charamisinau I; Nabi HA; Oseroff A; Pandey RK
J Med Chem; 2005 Oct; 48(20):6286-95. PubMed ID: 16190755
[TBL] [Abstract][Full Text] [Related]
34. Rhamnolipid nanoparticles for in vivo drug delivery and photodynamic therapy.
Yi G; Son J; Yoo J; Park C; Koo H
Nanomedicine; 2019 Jul; 19():12-21. PubMed ID: 30981820
[TBL] [Abstract][Full Text] [Related]
35. The chlorophyll catabolite pheophorbide a as a photosensitizer for the photodynamic therapy.
Xodo LE; Rapozzi V; Zacchigna M; Drioli S; Zorzet S
Curr Med Chem; 2012; 19(6):799-807. PubMed ID: 22214455
[TBL] [Abstract][Full Text] [Related]
36. Semi-synthesis and PDT activities of a new amphiphilic chlorin derivative.
Moritz MNO; Gonçalves JLS; Linares IAP; Perussi JR; de Oliveira KT
Photodiagnosis Photodyn Ther; 2017 Mar; 17():39-47. PubMed ID: 27769913
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-triphosphate nanoparticles for encapsulation of super-paramagnetic iron oxide as an MRI contrast agent.
Sanjai C; Kothan S; Gonil P; Saesoo S; Sajomsang W
Carbohydr Polym; 2014 Apr; 104():231-7. PubMed ID: 24607182
[TBL] [Abstract][Full Text] [Related]
38. Oxime-based 19-nortestosterone-pheophorbide a conjugate: bimodal controlled release concept for PDT.
Pavlíčková V; Jurášek M; Rimpelová S; Záruba K; Sedlák D; Šimková M; Kodr D; Staňková E; Fähnrich J; Rottnerová Z; Bartůněk P; Lapčík O; Drašar P; Ruml T
J Mater Chem B; 2019 Sep; 7(36):5465-5477. PubMed ID: 31414695
[TBL] [Abstract][Full Text] [Related]
39. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
[TBL] [Abstract][Full Text] [Related]
40. A Smart Photosensitizer-Cerium Oxide Nanoprobe for Highly Selective and Efficient Photodynamic Therapy.
Fan Y; Li P; Hu B; Liu T; Huang Z; Shan C; Cao J; Cheng B; Liu W; Tang Y
Inorg Chem; 2019 Jun; 58(11):7295-7302. PubMed ID: 31091081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
